First Time Loading...

Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP

Watchlist Manager
Corbus Pharmaceuticals Holdings Inc Logo
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Watchlist
Price: 42.8 USD 3.13% Market Closed
Updated: Jun 1, 2024

Corbus Pharmaceuticals Holdings Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corbus Pharmaceuticals Holdings Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Total Current Liabilities
$31.9m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
49%
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$41.5B
CAGR 3-Years
9%
CAGR 5-Years
24%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$13B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$19.7B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$3.8B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.6B
CAGR 3-Years
4%
CAGR 5-Years
19%
CAGR 10-Years
28%

See Also

What is Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities?
Total Current Liabilities
31.9m USD

Based on the financial report for Dec 31, 2023, Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities amounts to 31.9m USD.

What is Corbus Pharmaceuticals Holdings Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
49%

Over the last year, the Total Current Liabilities growth was 153%.